These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11763327)

  • 21. Poliovirus antigen chimeras.
    Rose CS; Evans DJ
    Trends Biotechnol; 1991 Dec; 9(12):415-21. PubMed ID: 1369352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic structure of poliovirus in inactivated vaccines.
    Ferguson M; Wood DJ; Minor PD
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of injectable and oral polio vaccines in polio eradication.
    John J
    Expert Rev Vaccines; 2009 Jan; 8(1):5-8. PubMed ID: 19093765
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant polioviruses as candidate strains of oral poliovaccines.
    Nomoto A
    Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
    [No Abstract]   [Full Text] [Related]  

  • 27. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.
    Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low oral poliovirus vaccine immunogenicity in developing countries.
    Orenstein WA; Garon JR
    Lancet Infect Dis; 2016 Aug; 16(8):868-9. PubMed ID: 27156190
    [No Abstract]   [Full Text] [Related]  

  • 30. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction of the information presented as reference.
    Shahmahmoodi S
    Vaccine; 2012 Nov; 30(48):6729; author reply 6730. PubMed ID: 22963802
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral polio vaccines and their role in polio eradication in India.
    Paul Y
    Expert Rev Vaccines; 2009 Jan; 8(1):35-41. PubMed ID: 19093771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of purification, inactivity and immunogenicity of antigenically chimeric poliovirus].
    Cai H; Dai C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Oct; 15(5):349-53. PubMed ID: 8168218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilisation of poliovirus with pirodavir.
    Rombaut B; Andries K; Boeyé A
    Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant polioviruses as candidates for oral live poliovaccines.
    Nomoto A
    Microbiol Immunol; 1993; 37(3):169-74. PubMed ID: 8391623
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of inactivated or oral poliovirus vaccine in India.
    Sehgal R
    Lancet; 1991 Oct; 338(8772):945. PubMed ID: 1681286
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in poliovirus antigenicity and their practical effects on vaccination].
    Hovi T
    Duodecim; 1988; 104(23-24):1936-46. PubMed ID: 2851432
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of mucosal immune response to viruses.
    Abraham R; Ogra PL
    Isr J Med Sci; 1994; 30(5-6):323-7. PubMed ID: 8034473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.